Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Dr. Mohammed Salama is Atlantic senior fellow for Equity in brain health at the Global Brain Health Institute (GBHI) and Associate professor at the Institute of Global Health and Human Ecology at the American University in Cairo (AUC). He established the first Translational Neuroscience Unit in Egypt. Mohamed’s collaborative research led to establishing the Egyptian Network for Neurodegenerative Disorders Mohamed was selected as a SOT Global Senior Scholar in 2013 and Translational/bridging awardee in 2016. He was awarded by Parkinson’s and Movement Disorders Foundation (PMDF) for his…mehr
Dr. Mohammed Salama is Atlantic senior fellow for Equity in brain health at the Global Brain Health Institute (GBHI) and Associate professor at the Institute of Global Health and Human Ecology at the American University in Cairo (AUC). He established the first Translational Neuroscience Unit in Egypt. Mohamed’s collaborative research led to establishing the Egyptian Network for Neurodegenerative Disorders Mohamed was selected as a SOT Global Senior Scholar in 2013 and Translational/bridging awardee in 2016. He was awarded by Parkinson’s and Movement Disorders Foundation (PMDF) for his continued research in neurodegeneration. Recently, Mohamed and his colleagues succeeded in drafting the first Reference Egyptian Genome and collaborating with other colleagues to start a national cohort (A Longitudinal Study of Egyptian Health Aging [AL-SEHA]).
Dr. Mohammed Salama is Atlantic senior fellow for Equity in brain health at the Global Brain Health Institute (GBHI) and Associate professor at the Institute of Global Health and Human Ecology at the American University in Cairo (AUC). He established the first Translational Neuroscience Unit in Egypt. Mohamed’s collaborative research led to establishing the Egyptian Network for Neurodegenerative Disorders Mohamed was selected as a SOT Global Senior Scholar in 2013 and Translational/bridging awardee in 2016. He was awarded by Parkinson’s and Movement Disorders Foundation (PMDF) for his continued research in neurodegeneration. Recently, Mohamed and his colleagues succeeded in drafting the first Reference Egyptian Genome and collaborating with other colleagues to start a national cohort (A Longitudinal Study of Egyptian Health Aging [AL-SEHA]).
Inhaltsangabe
Chapter 1. Nutrigenomics; a broader concept.- Chapter 2. Gene-environment interaction.- Chapter 3. Gene-gut-brain - axis (gene–based personalized medicine).- Chapter 4. Nutrigenomics of aging.- Chapter 5. Nutrigenomics and Mental health.- Chapter 6. Nutrigenomics and neurodevelopmental disorders.- Chapter 7. Nutrigenomics and Alzheimer’s disease.- Chapter 8. Nutrigenomics and Parkinson’s Disease.- Chapter 9. Nutrigenomics, nutrigenetics and big data.- Chapter 10. Nutrigenomics and Development.- Chapter 11. Early Child malnutrition and neurodevelopment.- Chapter 12. The emerging role of vit D deficiency and Parkinson’s Disease risk.- Chapter 13. Nutrigenomics and autophagy crosstalk.- Chapter 14. Nanoparticles in food additives and brain health.
Chapter 1. Nutrigenomics; a broader concept.- Chapter 2. Gene-environment interaction.- Chapter 3. Gene-gut-brain - axis (gene-based personalized medicine).- Chapter 4. Nutrigenomics of aging.- Chapter 5. Nutrigenomics and Mental health.- Chapter 6. Nutrigenomics and neurodevelopmental disorders.- Chapter 7. Nutrigenomics and Alzheimer's disease.- Chapter 8. Nutrigenomics and Parkinson's Disease.- Chapter 9. Nutrigenomics, nutrigenetics and big data.- Chapter 10. Nutrigenomics and Development.- Chapter 11. Early Child malnutrition and neurodevelopment.- Chapter 12. The emerging role of vit D deficiency and Parkinson's Disease risk.- Chapter 13. Nutrigenomics and autophagy crosstalk.- Chapter 14. Nanoparticles in food additives and brain health.
Chapter 1. Nutrigenomics; a broader concept.- Chapter 2. Gene-environment interaction.- Chapter 3. Gene-gut-brain - axis (gene–based personalized medicine).- Chapter 4. Nutrigenomics of aging.- Chapter 5. Nutrigenomics and Mental health.- Chapter 6. Nutrigenomics and neurodevelopmental disorders.- Chapter 7. Nutrigenomics and Alzheimer’s disease.- Chapter 8. Nutrigenomics and Parkinson’s Disease.- Chapter 9. Nutrigenomics, nutrigenetics and big data.- Chapter 10. Nutrigenomics and Development.- Chapter 11. Early Child malnutrition and neurodevelopment.- Chapter 12. The emerging role of vit D deficiency and Parkinson’s Disease risk.- Chapter 13. Nutrigenomics and autophagy crosstalk.- Chapter 14. Nanoparticles in food additives and brain health.
Chapter 1. Nutrigenomics; a broader concept.- Chapter 2. Gene-environment interaction.- Chapter 3. Gene-gut-brain - axis (gene-based personalized medicine).- Chapter 4. Nutrigenomics of aging.- Chapter 5. Nutrigenomics and Mental health.- Chapter 6. Nutrigenomics and neurodevelopmental disorders.- Chapter 7. Nutrigenomics and Alzheimer's disease.- Chapter 8. Nutrigenomics and Parkinson's Disease.- Chapter 9. Nutrigenomics, nutrigenetics and big data.- Chapter 10. Nutrigenomics and Development.- Chapter 11. Early Child malnutrition and neurodevelopment.- Chapter 12. The emerging role of vit D deficiency and Parkinson's Disease risk.- Chapter 13. Nutrigenomics and autophagy crosstalk.- Chapter 14. Nanoparticles in food additives and brain health.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497